Category page
Manufacturing companies in Europe — biotech directory
Biotech and pharma manufacturers run the production side of the drug development chain — drug substance synthesis, biologics fermentation, fill-finish, packaging, sterile manufacturing, API production, and supporting industrial chemistry. Unlike CDMOs (which manufacture for other companies under contract), this category captures companies that primarily produce their own products. Anchors include Boehringer Ingelheim, Bayer, Polpharma, Olainfarm, Roche manufacturing sites, Novo Nordisk, AstraZeneca, BioNTech production, and dozens of mid-scale specialists across Lithuania, Latvia, Poland, Germany, Switzerland, and the Nordics.
Where does this category cluster most clearly?
Manufacturing is currently most visible through Germany (4), Switzerland (4), Denmark (3), and Latvia (3). Top cities: Riga, Latvia (2), Tartu, Estonia (2), Basel, Switzerland (1), and Berlin, Germany (1). Most legible records: PharmaSynth, Kalceks, Eckert & Ziegler, and Octapharma.
Which standards and public evidence are already visible?
GMP (17) and ISO-13485 (5). Latest review: 21 March 2026. Review cycle: March 2026.
Why this category matters
This page brings companies and infrastructure records into one practical category view so users can compare markets and cities more quickly.
Related market brief
What the BIO CITY biotechnology city in Vilnius is, how Northway Biotech operates as the 2026 anchor tenant, which capabilities are live at BIO CITY Vilnius today, and how the multi-phase biotech city build-out is progressing — with sources.
Open related briefBy country
Manufacturing by country
Jump into a country-specific page filtered to this category only.
Explore more
Other categories
Full list
Manufacturing records
21 category records currently match the active filter.
Current review cycle
PharmaSynth
TartuEstoniaManufacturing
Tartu PET and SPECT precursor manufacturer operating from Tartu Science Park with GMP-aligned production, custom synthesis services, and small-scale API capability.
- Lead
- Pirkko Irene Penttila-HiltunenManagement Board Member
- Scale
- Specialty imaging-precursor and small-batch API platform
Current review cycle
Kalceks
RigaLatviaManufacturing
Riga pharmaceutical manufacturer developing, producing, registering, and distributing sterile hospital medicines and other finished dosage forms for international markets.
- Lead
- Egils KopstalsChairman of the Board
- Scale
- International finished-dosage manufacturing
Current review cycle
Eckert & Ziegler
BerlinGermanyManufacturing
Berlin radiopharma and isotope-products anchor spanning medical isotopes, radiation components, and nuclear-medicine supply.
- Lead
- Dr. Harald HasselmannChief Executive Officer
- Scale
- International isotope and radiopharma platform
Current review cycle
Octapharma
LachenSwitzerlandManufacturing
Lachen plasma and recombinant therapeutics anchor with a large international manufacturing and product-supply network.
- Lead
- Wolfgang MarguerreChairman and Chief Executive Officer
- Scale
- Global biologics manufacturing and supply
Current review cycle
Sandoz
BaselSwitzerlandManufacturing
Basel-headquartered generics and biosimilars anchor operating a global regulated manufacturing network across essential medicines.
- Lead
- Richard SaynorChief Executive Officer
- Scale
- Global regulated medicines supply
Current review cycle
WACKER Biotech
BurghausenGermanyManufacturing
Burghausen biosolutions and process-chemistry manufacturing anchor with large-scale industrial biotechnology and regulated process infrastructure.
- Lead
- Dr. Christian HartelPresident and Chief Executive Officer
- Scale
- Industrial and commercial manufacturing
Current review cycle
Gerresheimer
DüsseldorfGermanyManufacturing
Düsseldorf primary-packaging and drug-delivery systems anchor serving pharma and biotech manufacturing across Europe.
- Lead
- Uwe RöhrhoffInterim Chief Executive Officer
- Scale
- Global pharma industrial supply
Current review cycle
Bachem
BubendorfSwitzerlandManufacturing
Bubendorf peptide and oligonucleotide manufacturing anchor with a global API and GMP supply role for advanced therapeutics.
- Lead
- Anne-Kathrin StollerChief Executive Officer
- Scale
- Global GMP manufacturing
Current review cycle
Ypsomed
BurgdorfSwitzerlandManufacturing
Burgdorf injection-device and drug-delivery manufacturing anchor supporting regulated self-injection and digital-care products.
- Lead
- Simon MichelChief Executive Officer
- Scale
- Global delivery-device manufacturing
Current review cycle
Aconitum
KaunasLithuaniaManufacturing
Kaunas pharmaceutical and botanical-products manufacturer with a long-running formulation, extraction, and quality-control base serving the Lithuanian market.
- Lead
- Rima BalanaškienėFounder and Chief Executive Officer
- Scale
- Regional pharmaceutical manufacturing
Current review cycle
ALK-Abelló
HorsholmDenmarkManufacturing
Hørsholm allergy-immunotherapy headquarters and production-control node anchored in standardized vaccine manufacturing and quality systems.
- Lead
- Peter HallingPresident and Chief Executive Officer
- Scale
- Commercial specialty manufacturing
Current review cycle
Bavarian Nordic
KvistgaardDenmarkManufacturing
Kvistgaard vaccine-development and manufacturing anchor with commercial biodefense and travel-vaccine platforms operating inside a regulated global network.
- Lead
- Paul ChaplinPresident and Chief Executive Officer
- Scale
- Commercial vaccine manufacturing
Current review cycle
Novo Nordisk Kalundborg
KalundborgDenmarkManufacturing
Kalundborg is the flagship Danish industrial complex for API, biologics, and large-scale metabolic-disease manufacturing within Novo Nordisk's global network.
- Lead
- Lars Fruergaard JørgensenPresident and Chief Executive Officer
- Scale
- Global commercial manufacturing
Current review cycle
Sanobiotec
VilniusLithuaniaManufacturing
Vilnius biotech ingredients and white-label manufacturing platform operating with an ISO-backed quality system and a cannabinoid-processing focus.
- Lead
- Marijus JarockisChief Executive Officer
- Scale
- Regional manufacturing and export platform
Current review cycle
Lotos Pharma
MarupeLatviaManufacturing
Latvian pharmaceutical manufacturing platform in Marupe combining GMP-backed production, consumer health formulations, and locally developed bio-product lines.
- Lead
- Kaspars IvanovsHead of Company
- Scale
- Commercial manufacturing
Current review cycle
Merck KGaA
DarmstadtGermanyManufacturing
Darmstadt science and technology platform spanning life-science process materials, bioprocess inputs, and laboratory infrastructure.
- Lead
- Belen GarijoChair of the Executive Board and Chief Executive Officer
- Scale
- Global life science manufacturing
Current review cycle
Orion Corporation
EspooFinlandManufacturing
Espoo-headquartered pharmaceutical company combining API production, formulation, and neuroscience-focused R&D with regulated Finnish manufacturing operations.
- Lead
- Liisa HurmePresident and CEO
- Scale
- Global Market
Current review cycle
Silvanols
RigaLatviaManufacturing
Riga phytopharma manufacturer combining herbal formulation expertise, GMP-backed production, and regional natural-products manufacturing capacity.
- Lead
- Liene PurinaMember of the Board
- Scale
- Regional Supply
Current review cycle
Solis BioDyne
TartuEstoniaManufacturing
Tartu reagent manufacturer producing PCR enzymes, master mixes, and OEM-ready molecular biology inputs for diagnostics and research customers.
- Lead
- Ele ReiljanChairman of the Board and CEO
- Scale
- Global Supply
Current review cycle
Polfa Tarchomin
WarsawPolandManufacturing
Warsaw pharmaceutical manufacturing node focused on finished dosage and hospital supply infrastructure inside Poland's legacy industrial base. The verified March 2026 record follows the current official management board disclosure rather than third-party or outdated references.
- Lead
- Maksymilian ŚwiniarskiChief Executive Officer and President of the Management Board
- Scale
- Commercial manufacturing
Current review cycle
Valneva Sweden
StockholmSwedenManufacturing
Swedish Valneva operating site covering Stockholm and Solna coordinates within the company?s vaccine manufacturing and development network.
- Lead
- Thomas LingelbachChief Executive Officer, Member of the Board of Directors
- Scale
- Commercial scale
FAQ
Frequently asked questions
- What is the difference between a manufacturer and a CDMO?
- A manufacturer primarily produces its own drug substance, drug product, or device for its own pipeline or commercial supply. A CDMO (Contract Development and Manufacturing Organization) takes external programs from other companies — process transfer, scale-up, contract production. Some companies operate as both: manufacturing their own pipeline AND offering excess capacity to external clients.
- Which European countries have the most manufacturing capacity?
- Germany leads by industrial depth (Boehringer Ingelheim, Bayer, BioNTech production, Merck KGaA). Switzerland concentrates premium-tier sites (Roche, Novartis manufacturing). Denmark anchors aseptic/biologics scale (Novo Nordisk). Sweden adds AstraZeneca's Gothenburg base. Poland is competitive on cost (Polpharma, Adamed). Lithuania and Estonia have growing biologics manufacturing (Northway, Icosagen).
- What certifications should a biotech manufacturer hold?
- For drugs and biologics: GMP (essential, country-specific national authority enforces in EU). For medical devices: ISO 13485 + CE marking under MDR/IVDR. For US-bound supply: FDA inspection. For nonclinical studies: GLP. Use the /compliance pages on this directory to filter by specific markers — every published company has its certification context documented and source-backed.
- How are manufacturers verified in this directory?
- Every profile is hand-reviewed: leadership confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining current operating context and production scope.
Next step
Read the category, then move into cities and countries.
Use city pages for local concentration, country pages for market context, and the methodology page when you want to understand how records are reviewed.